Skip to content

Clinical trials

Purpura, Thrombocytopenic, Idiopathic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Clear all

481 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20012
20025
20035
20046
200510
20069
200716
20088
20097
201014
201115
201221
201312
201416
201516
201613
201717
201817
201922
202023
202133
202234
202332
202427
202554
202637

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed192
Unknown status101
Recruiting84
Not yet recruiting40
Withdrawn24
Terminated24
Active, not recruiting11
Enrolling by invitation2
Available2
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking University People's Hospital48
Shandong University38
Institute of Hematology & Blood Diseases Hospital, China32
Amgen18
Novartis Pharmaceuticals17
Assiut University13
GlaxoSmithKline11
University Hospital, Bordeaux11
Assistance Publique - Hôpitaux de Paris10
Sohag University10

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic481
Thrombocytopenia51
Purpura, Thrombocytopenic20
Purpura19
Anemia, Hemolytic, Autoimmune18
Lupus Erythematosus, Systemic17
Autoimmune Diseases16
Hematologic Diseases15
Hemorrhage12
Blood Platelet Disorders11

Trials

Showing 76 to 100 of 481. Each trial links to its page on Pharma Observatory.

381 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.